Immuron Limited Gains 42.27%

Tue, Jul 21, 2020 at 05:33 PM
Immuron Limited Gains 42.27%

Immuron Limited (IMRN:NASDAQ) rocketted at $14.81, a gain of 42.3%. On Mon 20 Jul 20, IMRN:NASDAQ touched a New 2-Week High of $10.41. The stock got featured on our News Catalysts scanner on Mon 20 Jul 20 at 06:43 AM in the 'BIOTECH' category. From Mon 06 Jul 20, the stock recorded 40.00% Up Days and 36.36% Green Days

The stock spiked on Mon 20 Jul 20 at $19.5 with a volume of 67M+.

About Immuron Limited (IMRN:NASDAQ)

Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.